^ ab“Synapse formation and function is modulated by the amyloid precursor protein”. The Journal of Neuroscience26 (27): 7212–21. (Jul 2006). doi:10.1523/JNEUROSCI.1450-06.2006. PMID16822978.
^“Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory”. Progress in Neurobiology70 (1): 1–32. (May 2003). doi:10.1016/S0301-0082(03)00089-3. PMID12927332.
^“Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]”. Nature Genetics5 (1): 22–30. (Sep 1993). doi:10.1038/ng0993-22. PMID8220418.
^“Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease”. Nature349 (6311): 704–6. (Feb 1991). doi:10.1038/349704a0. PMID1671712.
^“A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease”. Science254 (5028): 97–9. (Oct 1991). doi:10.1126/science.1925564. PMID1925564.
^“Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene”. Nature353 (6347): 844–6. (Oct 1991). doi:10.1038/353844a0. PMID1944558.
^“Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production”. Nature360 (6405): 672–4. (Dec 1992). doi:10.1038/360672a0. PMID1465129.
^“A mutation in APP protects against Alzheimer's disease and age-related cognitive decline”. Nature488 (7409): 96–9. (Aug 2012). doi:10.1038/nature11283. PMID22801501.
^“Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system”. The Journal of Neuroscience13 (7): 3136–42. (Jul 1993). PMID8331390.
^“Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein”. Nature Structural Biology6 (4): 327–31. (Apr 1999). doi:10.1038/7562. PMID10201399.; see also PDB ID 1MWP
^ ab“Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions”. Journal of Molecular Biology367 (1): 148–61. (Mar 2007). doi:10.1016/j.jmb.2006.12.041. PMID17239395.; See also 2007 PDB IDs 2FJZ, 2FK2, 2FKL.
^“Proteolytic processing and cell biological functions of the amyloid precursor protein”. Journal of Cell Science113 (11): 1857–70. (Jun 2000). PMID10806097.
^“TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity”. Nature440 (7088): 1208–12. (Apr 2006). doi:10.1038/nature04667. PMID16641999.
^“No hippocampal neuron or synaptic bouton loss in learning-impaired aged beta-amyloid precursor protein-null mice”. Neuroscience90 (4): 1207–16. (1999). doi:10.1016/S0306-4522(98)00645-9. PMID10338291.
^“Inverse correlation between amyloid precursor protein and synaptic plasticity in transgenic mice”. NeuroReport18 (10): 1083–7. (2007). doi:10.1097/WNR.0b013e3281e72b18. PMID17558301.
^“Amyloid-beta precursor protein expression and modulation in human embryonic stem cells: a novel role for human chorionic gonadotropin”. Biochemical and Biophysical Research Communications364 (3): 522–7. (Dec 2007). doi:10.1016/j.bbrc.2007.10.021. PMID17959150.
^“DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3”. The Journal of Neuroscience23 (17): 6914–27. (Jul 2003). PMID12890786.
^“Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition”. The Journal of Biological Chemistry279 (19): 20539–45. (May 2004). doi:10.1074/jbc.M311993200. PMID14871891.
^ abc“Regulation of APP-dependent transcription complexes by Mint/X11s: differential functions of Mint isoforms”. The Journal of Neuroscience22 (17): 7340–51. (Sep 2002). doi:10.1523/JNEUROSCI.22-17-07340.2002. PMID12196555.
^ ab“Novel cadherin-related membrane proteins, Alcadeins, enhance the X11-like protein-mediated stabilization of amyloid beta-protein precursor metabolism”. The Journal of Biological Chemistry278 (49): 49448–58. (Dec 2003). doi:10.1074/jbc.M306024200. PMID12972431.
^“Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein”. The Journal of Biological Chemistry274 (4): 2243–54. (Jan 1999). doi:10.1074/jbc.274.4.2243. PMID9890987.
^“X11L2, a new member of the X11 protein family, interacts with Alzheimer's beta-amyloid precursor protein”. Biochemical and Biophysical Research Communications255 (3): 663–7. (Feb 1999). doi:10.1006/bbrc.1999.0265. PMID10049767.
^“Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's beta-amyloid precursor proteins”. The Journal of Biological Chemistry272 (10): 6399–405. (Mar 1997). doi:10.1074/jbc.272.10.6399. PMID9045663.
^“Molecular cloning of human Fe65L2 and its interaction with the Alzheimer's beta-amyloid precursor protein”. Neuroscience Letters261 (3): 143–6. (Feb 1999). doi:10.1016/S0304-3940(98)00995-1. PMID10081969.
^“Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein”. The Journal of Biological Chemistry273 (50): 33556–60. (Dec 1998). doi:10.1074/jbc.273.50.33556. PMID9837937.
^“APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein”. The Journal of Biological Chemistry271 (19): 11339–46. (May 1996). doi:10.1074/jbc.271.19.11339. PMID8626687.
^“Uncleaved BAP31 in association with A4 protein at the endoplasmic reticulum is an inhibitor of Fas-initiated release of cytochrome c from mitochondria”. The Journal of Biological Chemistry278 (16): 14461–8. (Apr 2003). doi:10.1074/jbc.M209684200. PMID12529377.
^“Human bleomycin hydrolase regulates the secretion of amyloid precursor protein”. FASEB Journal14 (12): 1837–47. (Sep 2000). doi:10.1096/fj.99-0938com. PMID10973933.
^“Coordinated metabolism of Alcadein and amyloid beta-protein precursor regulates FE65-dependent gene transactivation”. The Journal of Biological Chemistry279 (23): 24343–54. (Jun 2004). doi:10.1074/jbc.M401925200. PMID15037614.
^“Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein”. The Journal of Biological Chemistry273 (17): 10485–95. (Apr 1998). doi:10.1074/jbc.273.17.10485. PMID9553108.
^“Fibulin-1 binds the amino-terminal head of beta-amyloid precursor protein and modulates its physiological function”. Journal of Neurochemistry76 (5): 1411–20. (Mar 2001). doi:10.1046/j.1471-4159.2001.00144.x. PMID11238726.
^“Binding of gelsolin, a secretory protein, to amyloid beta-protein”. Biochemical and Biophysical Research Communications258 (2): 241–6. (May 1999). doi:10.1006/bbrc.1999.0623. PMID10329371.
^“An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease”. Nature389 (6652): 689–95. (Oct 1997). doi:10.1038/39522. PMID9338779.
^“Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc”. The Journal of Biological Chemistry277 (19): 16798–804. (May 2002). doi:10.1074/jbc.M110286200. PMID11877420.
“Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome”. Annals of the New York Academy of Sciences695 (1 Transduction): 91–102. (Sep 1993). doi:10.1111/j.1749-6632.1993.tb23035.x. PMID8239320.
“Long time dynamic simulations: exploring the folding pathways of an Alzheimer's amyloid Abeta-peptide”. Accounts of Chemical Research35 (6): 473–81. (Jun 2002). doi:10.1021/ar010031e. PMID12069633.
“Pathogenic effects of cerebral amyloid angiopathy mutations in the amyloid beta-protein precursor”. Annals of the New York Academy of Sciences977 (1): 258–65. (Nov 2002). doi:10.1111/j.1749-6632.2002.tb04824.x. PMID12480759.
“Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease”. The International Journal of Biochemistry & Cell Biology35 (11): 1505–35. (Nov 2003). doi:10.1016/S1357-2725(03)00133-X. PMID12824062.
“Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development”. Journal of Neuroscience Research80 (2): 151–9. (Apr 2005). doi:10.1002/jnr.20408. PMID15672415.
“Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease”. Neurological Research27 (8): 869–81. (Dec 2005). doi:10.1179/016164105X49436. PMID16354549.
“[Recurrent intraparenchimal haemorrhages in a patient with cerebral amyloidotic angiopathy: description of one autopsy case]”. Pathologica98 (1): 44–7. (Feb 2006). PMID16789686.
“Does the p75 neurotrophin receptor mediate Abeta-induced toxicity in Alzheimer's disease?”. Journal of Neurochemistry98 (3): 654–60. (Aug 2006). doi:10.1111/j.1471-4159.2006.03905.x. PMID16893414.
“APP processing and the APP-KPI domain involvement in the amyloid cascade”. Neuro-Degenerative Diseases2 (6): 277–83. (2006). doi:10.1159/000092315. PMID16909010.